44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years. (HealthDay News) — For patients with hypertension, initiating treatment with ...

Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...

Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 billion people globally, with most living in low- and middle-income ...